A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 30 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors
  • Events
  • Conference: Impact Investing World Forum 2020
Conference - Event date: 24 Nov 2020

Impact Investing World Forum 2020

On Tuesday, 24 November 2020, Damiano de Felice, Director of Strategy at the Access to Medicine Foundation, will deliver a keynote speech at the Impact Investing World Forum 2020 virtual conference. Damiano will discuss impact investing in global health, drawing on the Foundation's work with 100+ institutional investors with over USD $15 trillion in assets under management.

The Impact Investing World Forum 2020 is a conference that aims to foster debate on social impact of all types of investments including social impact bonds, stocks, private equity, investment banking, venture capital, wealth management and family office. The two-day forum brings together banks, hedge funds, charitable foundations and trusts from around the world.

Damiano's presentation, titled 'Impact Investing in Global Health: From COVID-19 to Superbugs', will touch upon the important role that private capital and impact investing can play to support innovation and delivery of global health interventions.

Other keynote speakers participating in the Forum include:

  • Sir Ronald Cohen, Chair, GSG
  • Amit Bouri, CEO & Co-Founder, Global Impact Investing Network (GIIN)
  • Claire Hedley, Vice President, Goldman Sachs
  • James Gifford, Head, Impact Advisory, Credit Suisse

As of November 2020, 100+ investors – together managing assets of more than USD 15 trillion – have signed the Access to Medicine Index Investor Statement and committed to using the research of the Access to Medicine Foundation in their investment analysis and engagements with companies. Find out more about our work with investors here.

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.

Back to top |